Paper68814
Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
Yagoda A. Cancer Res, 1977. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer. Papers, record 68814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68814
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Cyclophosphamide | Major topic |
| Doxorubicin | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Bleomycin | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Methotrexate | |
| Neoplasm Metastasis |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39564123 | Evaluating nivolumab plus gemcitabine-cisplatin's cost-effectiveness for aUC in China. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39564123 | PubMed |
| 7230204 | Cytotoxic chemotherapy in carcinoma of the bladder: a review. | J R Soc Med | 1980 | https://conductscience.org/library/papers/7230204 | PubMed |
| 6685581 | Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6685581 | PubMed |
| 6416699 | Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG). | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6416699 | PubMed |
| 6265016 | The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/6265016 | PubMed |
| 3835175 | Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion. | Int Urol Nephrol | 1985 | https://conductscience.org/library/papers/3835175 | PubMed |
| 3311445 | Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3311445 | PubMed |
| 2647312 | Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2647312 | PubMed |
| 552498 | Treatment of infiltrating bladder cancer. | J R Soc Med | 1979 | https://conductscience.org/library/papers/552498 | PubMed |
| 389480 | Chemotherapy in the management of invasive bladder cancer. A review. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/389480 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/68814
GET https://conductscience.org/api/papers/v1/68814/authors